President Joe Biden said Nov. 17 that he intends to tap W. Kimryn Rathmell, MD, PhD, to lead the National Cancer Institute.

Portland, Maine-based Northern Light Mercy Hospital is partnering with Boston-based Dana Farber Cancer Institute.

Youth cancer mortality fell 24% in the past two decades, the CDC's National Center of Health Statistics found.

Decatur, Texas-based Wise Health System is relocating some of its oncology services and closing its radiation therapy services Dec. 1, The Messenger reported Nov. 15.

The national lung cancer five-year survival rate is 26.6%, but most states fall under the average.

Lung cancer survival rates jumped 4.6 percentage points in the last five years, and diagnosis rates have decreased 8%, according to the American Lung Association's 2023 "State of Lung Cancer" report released Nov. 7.

New York City-based NYU Langone Health's Perlmutter Cancer Center completed its first same-day spinal radiosurgery treatment for a patient.

Mishawaka, Ind.-based Franciscan Health Foundation received its largest gift ever, which will be used to create a new cancer center.

Wyoming has the fewest active oncologists per capita, with eight oncologists in the state.

A recent study found that CT scans are linked to an increased risk of blood cancer in young people.

Boston-based Dana-Farber Cancer Institute received a $72 million donation from the Pan-Mass Challenge, an athletic fundraiser.

The University of Texas MD Anderson Cancer Center in Houston has received a $25 million gift from Howard Meyers to establish a first-of-its-kind institute for oncology nursing.

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey are partnering on cancer care and research, including building three new facilities.

Here are 19 recent cancer center partnerships:

Duarte, Calif.-based City of Hope has selected Alan Bryce, MD, as the chief clinical officer of its Phoenix cancer center location, according to a Nov. 7 news release.

The District of Columbia has the highest number of active oncologists per capita.

Researchers from Tampa, Fla.-based Moffitt Cancer Center are investigating whether primary or metastatic tumors can be used to produce personalized neoantigen-targeted cancer vaccines.

The American Oncology Network has launched a foundation to provide cancer patients with funding for non-medical related expenses, the organization announced Nov. 3. 

Researchers at Boston-based Mass General Brigham have discovered a key mutation that may be a driving factor in resistance to certain drugs used to treat breast cancer patients, according to a Nov. 2 news release. 

Researchers at the National Cancer Institute may be inching closer to an improved type of T-cell therapy that could "supercharge" their response against solid tumors, according to a Nov. 1 news release.